The Online Investor
Healthcare M&A image Healthcare M&A » By The Online Investor Staff, updated Mon., Aug. 10, 1:28 AM Recent mergers and acquisitions in the Healthcare M&A category.

Slide #9. Boston Scientific IoGyn, Inc.

Acquirer: Boston Scientific (NYSE:BSX)
Acquiree: IoGyn, Inc.
Details: Boston Scientific Corporation (NYSE: BSX) has signed a definitive agreement to acquire IoGyn, Inc., a pre-commercial stage company. The transaction is expected to close within days. IoGyn has developed and received U.S. Food and Drug Administration (FDA) clearance for the Symphion System, a next generation system for hysteroscopic intrauterine tissue removal including fibroids (myomas) and polyps. This acquisition enables the pairing of the Symphion System with the Boston Scientific Genesys HTA System for abnormal uterine bleeding, to create a compelling set of gynecologic surgery products.

Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.

Boston Scientific SEC Filing Email Alerts Service


Open the BSX Page at The Online Investor »

Company Name: 
Boston Scientific Corp.
Website: 
www.bostonscientific.com
Sector: 
Medical Instruments & Supplies
Number of ETFs Holding BSX: 
71
Total Market Value Held by ETFs: 
$5.51B
Total Market Capitalization: 
$53.97B
% of Market Cap. Held by ETFs: 
10.21%
 

Open the BSX Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (3.72 out of 4)
74th percentile
(ranked higher than approx. 74% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Healthcare M&A - Slide 9 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.